Aerosol Delivery Device Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Aerosol Delivery Device Market is segmented By Product (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers) By Applications (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Non-Respiratory Diseases) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global aerosol delivery device market reached US$ YY&nbsp;million in 2023&nbsp;and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Aerosol is a suspension system of solid or liquid particles in a gas, typically air. It allows for medication to be delivered directly to the bloodstream through the lungs, without the complications of an IV, such as pain and injection site infection. This technique is primarily used for dosing medication for lung conditions, including asthma, but it may be beneficial for other therapies as well.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product, Application, Distribution Channel
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/aerosol-delivery-device-market" target="_blank">Request for Sample</a>

&nbsp;

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Growing Prevalence of Respiratory Diseases

The growing prevalence of respiratory diseases is expected to boost the global market growth during the forecast period. For instance, according to the World Health Organization (WHO) 2021 factsheet, COPD was among the third-leading reason of death globally, inducing 3.23 million casualties in 2020. More than 80% of these casualties happened in low and middle-income countries (LMIC).&nbsp;

Also, according to the Asthma and Allergy Foundation of America in March 2021, approximately 1 in 13 Americans had asthma, which was approximately 25 million individuals. Asthma is among the biggest contributors to this formation, involving children, adults, and geriatric individuals. The same reference remarked that almost 5 million American children had asthma.

Furthermore, the technological advancements, rise in research activities, increaseing investments and growing awareness are among the other additional factors boosting the global market growth during the forecast period.

Product Recalls

The increasing incidences of product recalls from market are expected to hamper the global market growth during the forecast period. for instance, Cipla Limited&#39;s wholly-owned associate, Cipla USA Inc., willingly recalled six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer level with the knowledge of the U.S. Food and Drug Administration. Furthermore, stringent regulatory bodies, and high development costs are other additional factors hampering the global market growth during the forecast period.

<h3>Segment Analysis</h3>

The global aerosol delivery device market is segmented based on product, application, distribution channel and region.

Metered Dose Inhalers are Expected to Dominate Market

Owing to the increasing authorizations from the regulatory bodies for metered dose inhalers, the segment is expected to dominate the global market during the forecast period. For instance, in October 2021, BreatheSuite obtained 510(k) authorization from the FDA for its Metered-Dose Inhaler V1 device, which turns existing inhalers into smart inhalers for individuals with asthma and COPD. Moreover, in July 2023, Lupin&#39;s subsidiary unit Hormosan Pharma GmbH introduced a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany.

<h3>Geographical Analysis</h3>

North America is Expected to Dominate the Global Market 

Owing to the increasing approvals in North America the region is expected to dominate the global market during the forecast period. For instance, in July 2023, Viatris Inc., a multinational healthcare corporation, and Kindeva Drug Delivery introduced Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the foremost generic version of AstraZeneca&#39;s Symbicort with an Abbreviated New Drug Application (ANDA) authorized by the U.S. Food and Drug Administration (FDA). Moreover, in February 2020, The US Food and Drug Administration (FDA) authorized the foremost generic of ProAir HFA (albuterol sulfate) inhalation aerosol to treat or prevent bronchospasm in individuals of four years of age and older with reversible obstructive airway disease and prevention of exercise-induced bronchospasm in patients four years of age and older.

<h3>COVID-19 Impact Analysis</h3>

As SARS-CoV-2 directly targets the lungs and initiates lung damage, treating COVID-19 with inhalants presents multiple benefits over the enteral/parenteral administration. Inhaled drug delivery delivers higher drug concentrations, particularly in the pulmonary system. This allows the lessening of systemic side effects and delivers a quick clinical reaction, therefore, the pandemic has led to an increase in the demand for and investments in aerosol delivery devices, positively impacting the global market during the pandemic.

<h3>Key Developments</h3>

<ul>
	<li>In June 2022, United Therapeutics Corporation obtained FDA authorization for its Tyvaso DPI, an inhalation powder to treat pulmonary arterial hypertension and pulmonary hypertension linked with interstitial lung diseases.&nbsp;</li>
	<li>In January 2023, AstraZeneca obtained authorization from the U.S. Food and Drug Administration for Airsupra (albuterol and budesonide) inhalation aerosol. Airsupra strives to decrease the threat of asthma exacerbations in people aged 18 years and older.</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the market include 3M Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Cipla Inc., Boehringer Ingelheim International GmbH, AstraZeneca, Pfizer Inc, Merck &amp; Co., Inc., Genentech USA, Inc. and MannKind Corporation among others.

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global aerosol delivery device market segmentation based on product, application, distribution channel and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of aerosol delivery device market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global aerosol delivery device market report would provide approximately 62 tables, 58 figures and 184 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product</li>
		<li>Snippet by Application</li>
		<li>Snippet by Distribution Channel</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Growing Prevalence of Respiratory Diseases</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Product Recalls</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Patent Analysis</li>
		<li>Product Trend</li>
		<li>Unmet Need</li>
		<li>Epidemiology Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>Dry Powder Inhalers*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Metered Dose Inhalers</li>
		<li>Nebulizers</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Asthma*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Chronic Obstructive Pulmonary Disease (COPD)</li>
		<li>Cystic Fibrosis</li>
		<li>Non-Respiratory Diseases</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel</li>
		</ol>
		</li>
		<li>Hospital Pharmacies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Retail Pharmacies</li>
		<li>Online Pharmacies</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>3M Company, Inc.*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>GlaxoSmithKline plc</li>
		<li>Teva Pharmaceutical Industries Ltd., Inc.</li>
		<li>Cipla Inc.</li>
		<li>Boehringer Ingelheim International GmbH</li>
		<li>AstraZeneca,</li>
		<li>Pfizer Inc</li>
		<li>Merck &amp; Co., Inc.</li>
		<li>Genentech USA, Inc.</li>
		<li>MannKind Corporation&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Aerosol Delivery Device Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Aerosol Delivery Device Market Value, By Applications, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Aerosol Delivery Device Market Value, By Distribution Channel, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Aerosol Delivery Device Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Aerosol Delivery Device Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Aerosol Delivery Device Market Value, By Product, 2022-2031 (US$ Million)

Table 7 Global Aerosol Delivery Device Market Value, By Applications, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Aerosol Delivery Device Market Value, By Applications, 2022-2031 (US$ Million)

Table 9 Global Aerosol Delivery Device Market Value, By Distribution Channel, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Aerosol Delivery Device Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 11 Global Aerosol Delivery Device Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Aerosol Delivery Device Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Aerosol Delivery Device Market Value, By Product, 2022-2031 (US$ Million)

Table 14 North America Aerosol Delivery Device Market Value, By Applications, 2022-2031 (US$ Million)

Table 15 North America Aerosol Delivery Device Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 16 North America Aerosol Delivery Device Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Aerosol Delivery Device Market Value, By Product, 2022-2031 (US$ Million)

Table 18 South America Aerosol Delivery Device Market Value, By Applications, 2022-2031 (US$ Million)

Table 19 South America Aerosol Delivery Device Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 20 South America Aerosol Delivery Device Market Value, By 0, 2022-2031 (US$ Million)

Table 21 South America Aerosol Delivery Device Market Value, By Country, 2022-2031 (US$ Million)

Table 22 Europe Aerosol Delivery Device Market Value, By Product, 2022-2031 (US$ Million)

Table 23 Europe Aerosol Delivery Device Market Value, By Applications, 2022-2031 (US$ Million)

Table 24 Europe Aerosol Delivery Device Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 25 Europe Aerosol Delivery Device Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Aerosol Delivery Device Market Value, By Product, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Aerosol Delivery Device Market Value, By Applications, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Aerosol Delivery Device Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 29 Asia-Pacific Aerosol Delivery Device Market Value, By Country, 2022-2031 (US$ Million)

Table 30 Middle East &amp; Africa Aerosol Delivery Device Market Value, By Product, 2022-2031 (US$ Million)

Table 31 Middle East &amp; Africa Aerosol Delivery Device Market Value, By Applications, 2022-2031 (US$ Million)

Table 32 Middle East &amp; Africa Aerosol Delivery Device Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 33 3M Company, Inc.: Overview

Table 34 3M Company, Inc.: Product Portfolio

Table 35 3M Company, Inc.: Key Developments

Table 36 GlaxoSmithKline plc: Overview

Table 37 GlaxoSmithKline plc: Product Portfolio

Table 38 GlaxoSmithKline plc: Key Developments

Table 39 Teva Pharmaceutical Industries Ltd., Inc.: Overview

Table 40 Teva Pharmaceutical Industries Ltd., Inc.: Product Portfolio

Table 41 Teva Pharmaceutical Industries Ltd., Inc.: Key Developments

Table 42 Cipla Inc.: Overview

Table 43 Cipla Inc.: Product Portfolio

Table 44 Cipla Inc.: Key Developments

Table 45 Boehringer Ingelheim International GmbH: Overview

Table 46 Boehringer Ingelheim International GmbH: Product Portfolio

Table 47 Boehringer Ingelheim International GmbH: Key Developments

Table 48 AstraZeneca: Overview

Table 49 AstraZeneca: Product Portfolio

Table 50 AstraZeneca: Key Developments

Table 51 Pfizer Inc: Overview

Table 52 Pfizer Inc: Product Portfolio

Table 53 Pfizer Inc: Key Developments

Table 54 Merck &amp; Co., Inc.: Overview

Table 55 Merck &amp; Co., Inc.: Product Portfolio

Table 56 Merck &amp; Co., Inc.: Key Developments

Table 57 Genentech USA, Inc.: Overview

Table 58 Genentech USA, Inc.: Product Portfolio

Table 59 Genentech USA, Inc.: Key Developments

Table 60 MannKind Corporation: Overview

Table 61 MannKind Corporation: Product Portfolio

Table 62 MannKind Corporation: Key Developments

List of Figures

Figure 1 Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 2 Global Aerosol Delivery Device Market Share, By Product, 2022 &amp; 2031 (%)

Figure 3 Global Aerosol Delivery Device Market Share, By Applications, 2022 &amp; 2031 (%)

Figure 4 Global Aerosol Delivery Device Market Share, By Distribution Channel, 2022 &amp; 2031 (%)

Figure 5 Global Aerosol Delivery Device Market Share, By Region, 2022 &amp; 2031 (%)

Figure 6 Global Aerosol Delivery Device Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 7 Dry Powder Inhalers Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 8 Metered Dose Inhalers Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 9 Nebulizers Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 10 Global Aerosol Delivery Device Market Y-o-Y Growth, By Applications, 2022-2031 (%)

Figure 11 Asthma Applications in Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 12 Chronic Obstructive Pulmonary Disease (COPD) Applications in Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 13 Cystic Fibrosis Applications in Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 14 Non-Respiratory Diseases Applications in Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 15 Global Aerosol Delivery Device Market Y-o-Y Growth, By Distribution Channel, 2022-2031 (%)

Figure 16 Hospital Pharmacies Distribution Channel in Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 17 Retail Pharmacies Distribution Channel in Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 18 Online Pharmacies Distribution Channel in Global Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 19 Global Aerosol Delivery Device Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 20 North America Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 21 Asia-Pacific Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 22 Europe Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 23 South America Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 24 Middle East and Africa Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 25 North America Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 26 North America Aerosol Delivery Device Market Share, By Product, 2022 &amp; 2031 (%)

Figure 27 North America Aerosol Delivery Device Market Share, By Applications, 2022 &amp; 2031 (%)

Figure 28 North America Aerosol Delivery Device Market Share, By Distribution Channel, 2022 &amp; 2031 (%)

Figure 29 North America Aerosol Delivery Device Market Share, By Country, 2022 &amp; 2031 (%)

Figure 30 South America Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 31 South America Aerosol Delivery Device Market Share, By Product, 2022 &amp; 2031 (%)

Figure 32 South America Aerosol Delivery Device Market Share, By Applications, 2022 &amp; 2031 (%)

Figure 33 South America Aerosol Delivery Device Market Share, By Distribution Channel, 2022 &amp; 2031 (%)

Figure 34 South America Aerosol Delivery Device Market Share, By Country, 2022 &amp; 2031 (%)

Figure 35 Europe Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 36 Europe Aerosol Delivery Device Market Share, By Product, 2022 &amp; 2031 (%)

Figure 37 Europe Aerosol Delivery Device Market Share, By Applications, 2022 &amp; 2031 (%)

Figure 38 Europe Aerosol Delivery Device Market Share, By Distribution Channel, 2022 &amp; 2031 (%)

Figure 39 Europe Aerosol Delivery Device Market Share, By Country, 2022 &amp; 2031 (%)

Figure 40 Asia-Pacific Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 41 Asia-Pacific Aerosol Delivery Device Market Share, By Product, 2022 &amp; 2031 (%)

Figure 42 Asia-Pacific Aerosol Delivery Device Market Share, By Applications, 2022 &amp; 2031 (%)

Figure 43 Asia-Pacific Aerosol Delivery Device Market Share, By Distribution Channel, 2022 &amp; 2031 (%)

Figure 44 Asia-Pacific Aerosol Delivery Device Market Share, By Country, 2022 &amp; 2031 (%)

Figure 45 Middle East &amp; Africa Aerosol Delivery Device Market Value, 2022-2031 (US$ Million)

Figure 46 Middle East &amp; Africa Aerosol Delivery Device Market Share, By Product, 2022 &amp; 2031 (%)

Figure 47 Middle East &amp; Africa Aerosol Delivery Device Market Share, By Applications, 2022 &amp; 2031 (%)

Figure 48 Middle East &amp; Africa Aerosol Delivery Device Market Share, By Distribution Channel, 2022 &amp; 2031 (%)

Figure 49 3M Company, Inc.: Financials

Figure 50 GlaxoSmithKline plc: Financials

Figure 51 Teva Pharmaceutical Industries Ltd., Inc.: Financials

Figure 52 Cipla Inc.: Financials

Figure 53 Boehringer Ingelheim International GmbH: Financials

Figure 54 AstraZeneca: Financials

Figure 55 Pfizer Inc: Financials

Figure 56 Merck &amp; Co., Inc.: Financials

Figure 57 Genentech USA, Inc.: Financials

Figure 58 MannKind Corporation: Financials

Aerosol Delivery Device Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Dry Powder Inhalers Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 25

Starting from

Smart Inhalers Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 April 06

Starting from

Inhalation Therapy Nebulizer Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 December 28

Starting from

Respiratory Inhalers Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 December 05

Starting from